Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 08:00 am Sale | 2026-05-31 | 13G | CAESARS ENTMT INC CZR | COHEN & STEERS INC. CNS | 4,745,710 2.330% | -7,507,919 (-61.27%) | Filing History |
| 2026-05-15 09:00 am Sale | 2026-03-31 | 13G | CAESARS ENTMT INC CZR | COHEN & STEERS INC. CNS | 12,253,629 6.020% | -2,910,013 (-19.19%) | Filing History |
| 2026-04-29 5:05 pm Purchase | 2026-03-31 | 13G | CAESARS ENTMT INC CZR | VANGUARD CAPITAL MANAGEMENT LLC | 10,348,986 5.080% | 10,348,986 (New Position) | Filing History |
| 2026-04-29 12:26 pm Purchase | 2026-03-31 | 13G | CAESARS ENTMT INC CZR | Vanguard Portfolio Management | 10,383,790 5.100% | 10,383,790 (New Position) | Filing History |
| 2026-03-26 4:43 pm Sale | 2026-03-13 | 13G | CAESARS ENTMT INC CZR | VANGUARD GROUP INC | 0 0.000% | -23,559,890 (Position Closed) | Filing History |
| 2026-02-12 10:25 am Sale | 2025-12-31 | 13G | CAESARS ENTMT INC CZR | Capital Research Global Investors | 9,915,236 4.900% | -5,402,705 (-35.27%) | Filing History |
| 2025-12-04 2:24 pm Purchase | 2025-11-30 | 13G | CAESARS ENTMT INC CZR | BlackRock, Inc. BLK | 23,370,759 11.500% | 14,174,576 (+154.14%) | Filing History |
| 2025-11-13 7:06 pm Purchase | 2025-09-30 | 13G | CAESARS ENTMT INC CZR | Capital World Investors | 16,193,070 7.800% | 5,168,622 (+46.88%) | Filing History |
| 2025-11-13 10:29 am Sale | 2025-09-30 | 13G | CAESARS ENTMT INC CZR | Capital Research Global Investors | 15,317,941 7.400% | -4,493,978 (-22.68%) | Filing History |
| 2025-10-17 6:05 pm Sale | 2025-09-30 | 13G | CAESARS ENTMT INC CZR | BlackRock, Inc. BLK | 9,196,183 4.400% | -5,689,014 (-38.22%) | Filing History |
| 2025-05-15 08:50 am Purchase | 2025-03-31 | 13G | CAESARS ENTMT INC CZR | COHEN & STEERS INC. CNS | 15,163,642 7.150% | 2,268,441 (+17.59%) | Filing History |
| 2025-02-14 11:35 am Sale | 2024-12-31 | 13G | CAESARS ENTMT INC CZR | JANUS HENDERSON GROUP PLC JHG | 7,101,885 3.300% | -5,507,358 (-43.68%) | Filing History |
| 2025-02-13 2:14 pm Purchase | 2024-12-31 | 13G | CAESARS ENTMT INC CZR | Capital Research Global Investors | 19,811,919 9.300% | 2,555,876 (+14.81%) | Filing History |
| 2024-11-14 11:11 am Purchase | 2024-09-30 | 13G | CAESARS ENTMT INC CZR | COHEN & STEERS INC. CNS | 12,895,201 5.960% | 12,895,201 (New Position) | Filing History |
| 2024-11-14 10:31 am Purchase | 2024-09-30 | 13G | CAESARS ENTMT INC CZR | JANUS HENDERSON GROUP PLC JHG | 12,609,243 5.900% | 3,225,781 (+34.38%) | Filing History |
| 2024-11-12 12:52 pm Purchase | 2024-11-07 | 13G | CAESARS ENTMT INC CZR | Capital Research Global Investors | 17,256,043 8.000% | 5,040,758 (+41.27%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | CAESARS ENTMT INC CZR | BlackRock, Inc. BLK | 14,885,197 6.900% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Sale | 2024-09-30 | 13G | CAESARS ENTMT INC CZR | BlackRock, Inc. BLK | 14,885,197 6.900% | -2,487,565 (-14.32%) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | CAESARS ENTMT INC CZR | VANGUARD GROUP INC | 23,559,890 10.920% | 780,830 (+3.43%) | Filing History |
| 2024-02-12 12:11 pm Sale | 2023-12-31 | 13G | CAESARS ENTMT INC CZR | JANUS HENDERSON GROUP PLC JHG | 9,383,462 4.400% | -2,915,465 (-23.71%) | Filing History |